TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21798991

Group type: EXPERIMENTAL
Intervention: One-day interval (Mifepristone 200 mg followed by Misoprostol 400 mcg after 17-28 hours)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Two-day interval (Mifepristone 200 mg followed by Misoprostol 400 mcg after 41-45 hours)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Two-day interval
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: One-day interval
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: One-day interval among women without previous vaginal deliveries
Number of subjects: 227

Group type: COMPARATOR
Intervention: Two-day interval among women without previous vaginal deliveries
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: One-day interval when gestation exceeded 16 weeks
Number of subjects: 227

Group type: COMPARATOR
Intervention: Two-day interval when gestation exceeded 16 weeks
Number of subjects: 227
Study: 17702040

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (5,000 units, three times weekly subcutaneously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin
Number of subjects: 12
Study: 15599490

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SNB) without elective neck dissection
Number of subjects: 70

Group type: COMPARATOR
Intervention: Postoperative observation of neck node metastases
Number of subjects: 70
Study: 12225327

Group type: EXPERIMENTAL
Intervention: Consensus interferon (CIFN) induction therapy for one month followed by standard 9 microg of CIFN thrice weekly for 11 months
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Rapid viral response (RVR) during the first month of induction dosing
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Induction dosing with CIFN
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Early viral kinetics during the first month of therapy
Number of subjects: 173
Study: 15641227

Group type: EXPERIMENTAL
Intervention: Eradication treatment (Pantoprazole 40 mg 1x/day, Amoxycillin 1000 2x/day, Claritromycin 500 2x/day)
Number of subjects: 251
Study: 8787478

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional therapy (hyperventilation, inspired oxygen fraction of 0.80, and inotropic agents)
Number of subjects: 20
Study: 2313319

Group type: EXPERIMENTAL
Intervention: Kidney Disease Questionnaire (KDQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental education program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Starting dialysis
Number of subjects: 0
Study: 7440192

Group type: EXPERIMENTAL
Intervention: Heparin (3 x 5000 IU/day)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Heparin (2 x 5000 IU/day) + 0.5 mg dihydroergot (DHE)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Physiotherapy (intermittent compression stockings + physical exercise)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Phlebography
Number of subjects: 227

Group type: COMPARATOR
Intervention: Doppler
Number of subjects: 227
Study: 31812878

Group type: EXPERIMENTAL
Intervention: Ibudilast (IBUD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31546685

Group type: EXPERIMENTAL
Intervention: Morning exercise group
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Evening exercise group
Number of subjects: 71

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 71
Study: 28938219

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.5mg/kg
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 104
Study: 26416604

Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 732

Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 732

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 732

Group type: COMPARATOR
Intervention: High-fat diet
Number of subjects: 732
Study: 22886533

Group type: EXPERIMENTAL
Intervention: CT in the trauma room
Number of subjects: 1124
Study: 21078382

Group type: EXPERIMENTAL
Intervention: Arsenic methylation to dimethylarsinic acid (DMA)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Arsenic methylation to monomethylated metabolite
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Nutritional status (including vitamin B12 and folate)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Urinary excretion of arsenic
Number of subjects: 324
Study: 19844090

Group type: EXPERIMENTAL
Intervention: Formula with B. lactis
Number of subjects: 525

Group type: COMPARATOR
Intervention: Formula without B. lactis
Number of subjects: 525
Study: 16915978

Group type: EXPERIMENTAL
Intervention: Function-related tests (hand to neck, hand to scapula, hand to opposite scapula)
Number of subjects: 46
Study: 15260876

Group type: EXPERIMENTAL
Intervention: High DHA levels in mothers at birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low DHA levels in mothers at birth
Number of subjects: 0
Study: 11753595

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Orlistat during extension phase
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 294
Study: 9425508

Group type: EXPERIMENTAL
Intervention: Continuous risedronate 2.5 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cyclic risedronate 2.5 mg
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 8503714

Group type: EXPERIMENTAL
Intervention: 240 mg verapamil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mg enalapril
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both drugs simultaneously
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both products (verapamil and enalapril)
Number of subjects: 40
Study: 3620826

Group type: EXPERIMENTAL
Intervention: Hexabrix (320 mg iodine/ml)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Iopamiron (300 mg iodine/ml)
Number of subjects: 97

Group type: COMPARATOR
Intervention: iohexol (300 mg iodine/ml)
Number of subjects: 97
Study: 29329567

Group type: EXPERIMENTAL
Intervention: 6-week course of Modified Pilates (MP) classes in addition to standard physiotherapy care
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard physiotherapy care only
Number of subjects: 73
Study: 27302000

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol
Number of subjects: 77

Group type: COMPARATOR
Intervention: Fractionated propofol administration (FPA)
Number of subjects: 77
Study: 24925227

Group type: EXPERIMENTAL
Intervention: Culturally and linguistically tailored telephone-delivered intervention; 10 phone calls to address challenges and barriers to care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-control arm
Number of subjects: 0
Study: 23250252

Group type: EXPERIMENTAL
Intervention: Home blood pressure measurement (HBPM) with educational activities
Number of subjects: 290

Group type: COMPARATOR
Intervention: Routine treatment (Control group)
Number of subjects: 290
Study: 20513222

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional Ventilation
Number of subjects: 3
Study: 19010947

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet
Number of subjects: 7

Group type: COMPARATOR
Intervention: Protein-rich diet
Number of subjects: 7
Study: 16221311

Group type: EXPERIMENTAL
Intervention: General practitioner care plus a program of care based on the McKenzie Method
Number of subjects: 148

Group type: COMPARATOR
Intervention: General practitioner care
Number of subjects: 148
Study: 12163917

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) - 30 mg/kg body weight in three divided daily doses
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) - 25 mg/kg body weight of sulfadoxine and 1.25 mg/kg of pyrimethamine in a single oral dose
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine-amodiaquine combination (SP+AQ) - same doses as in SP and AQ, given simultaneously on day 0
Number of subjects: 191
Study: 10408318

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate beverage ingestion (C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo beverage ingestion (P)
Number of subjects: 10
Study: 7587701

Group type: EXPERIMENTAL
Intervention: B ultrasound
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Thallium-technetium scanning (TTS)
Number of subjects: 41
Study: 2328557

Group type: EXPERIMENTAL
Intervention: 60 mg/day fluoxetine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 40 mg/day fluoxetine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 376894

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Epinephrine and aminophylline
Number of subjects: 44
Study: 31846088

Group type: EXPERIMENTAL
Intervention: Fish protein hydrolysate (FPH)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Whey protein hydrolysate (WPH)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study: 29483485

Group type: EXPERIMENTAL
Intervention: Laminoplasty in patients with kyphosis and CSM (KC group)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Laminoplasty in patients with lordosis and CSM (LC group)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Laminoplasty in patients with kyphosis and OPLL (KO group)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Laminoplasty in patients with lordosis and OPLL (LO group)
Number of subjects: 137
Study: 26427719

Group type: EXPERIMENTAL
Intervention: Students for Nutrition and eXercise (SNaX) intervention
Number of subjects: 1520
Study: 25580087

Group type: EXPERIMENTAL
Intervention: Dobutamine treatment to maintain StO2 ≥ 80%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care algorithm
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dobutamine treatment
Number of subjects: 50
Study: 22814041

Group type: EXPERIMENTAL
Intervention: Cataract surgery with iStent trabecular micro-bypass stent implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 0
Study: 20386555

Group type: EXPERIMENTAL
Intervention: Active treatment arm
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Steroids before study entry
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spine surgery before enrollment
Number of subjects: 50
Study: 18339790

Group type: EXPERIMENTAL
Intervention: Inhaled mannitol (420 mg, twice daily for 2 weeks)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 15975155

Group type: EXPERIMENTAL
Intervention: Glucose (50 g carbohydrate drink)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sucrose (50 g carbohydrate drink)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water (300 ml)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fructose (50 g carbohydrate drink)
Number of subjects: 10
Study: 12788569

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 5165
Study: 11424660

Group type: EXPERIMENTAL
Intervention: Cortisol levels in patients with unstable coronary disease (group I)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cortisol levels in patients with acute myocardial infarction (group II)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cortisol levels in healthy volunteers (control group)
Number of subjects: 75
Study: 8785133

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg kg‐1 i.v. at peritoneal closure after hysterectomy (group post)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg kg‐1 on induction of anaesthesia (group pre‐low)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: morphine 0.3 mg kg‐1 on induction of anaesthesia (group pre‐high)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: morphine 0.3 mg kg‐1 i.v. on induction of anaesthesia (group pre‐high)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study: 1468273

Group type: EXPERIMENTAL
Intervention: Fructose diet (20% of energy from fructose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Starch diet (<3% of energy from fructose)
Number of subjects: 18
Study: 6387754

Group type: EXPERIMENTAL
Intervention: Social work intervention with attached social workers in general practice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine treatment by their doctor (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Social work intervention
Number of subjects: 80
Study: 29295652

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 80
Study: 28415135

Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage (twice a day for 14 days)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Enteral feeding improvement massage (in feeding-intolerant subgroup)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham exercise (control group)
Number of subjects: 55
Study: 26935474

Group type: EXPERIMENTAL
Intervention: Audio Feedback with Reduced Self-focus (AF with RS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Audio Feedback only (AF only)
Number of subjects: 41
Study: 26121801

Group type: EXPERIMENTAL
Intervention: ORS group (1,500 ml ORS 6 to 2 hours before anesthesia)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (nothing by mouth from 6 hours before anesthesia)
Number of subjects: 20
Study: 22433176

Group type: EXPERIMENTAL
Intervention: OVK program (cognitive-behavioral and social problem-solving skills) delivered by trained school teachers during school hours.
Number of subjects: 1324

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 1324

Group type: EXPERIMENTAL
Intervention: OVK program (cognitive-behavioral and social problem-solving skills).
Number of subjects: 1324
Study: 20299238

Group type: EXPERIMENTAL
Intervention: Serum MCP-1 concentrations measured at baseline (mean 46 h), 12 weeks, and 24 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Serum MCP-1 concentrations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MMP-3, MMP-9, and MMP-2 concentrations measured at each time-point
Number of subjects: 100
Study: 18417894

Group type: EXPERIMENTAL
Intervention: 1% povidone‐iodine mouthwash
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no mouthwash)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Salt/soda mouthwash
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthwash
Number of subjects: 80
Study: 16027631

Group type: EXPERIMENTAL
Intervention: Transbond Plus Self‐Etching Primer (3M Unitek)
Number of subjects: 22

Group type: COMPARATOR
Intervention: One‐Step Self‐Etching Primer (Reliance)
Number of subjects: 22
Study: 12012316

Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All‐trans retinoic acid (ATRA) and anthracycline‐based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: ATRA-based regimens
Number of subjects: 0
Study: 10713869

Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide 150 micrograms kg‐1 and ondansetron 100 micrograms kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ondansetron 150 micrograms kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 250 micrograms kg‐1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 100
Study: 8935189

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) intravenously
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) orally
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CSA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 96
Study: 1756217

Group type: EXPERIMENTAL
Intervention: Bifluorid 12 (6% sodium fluoride and 6% calcium fluoride)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Laweflour‐Schüttellack (5% sodium fluoride)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 400
Study: 6384161

Group type: EXPERIMENTAL
Intervention: Misonidazole (2.0 gm/m2) with each of six fractions of 6.0 Gy in hyperbaric oxygen at 3 ATA
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of sensitizers (misonidazole and hyperbaric oxygen)
Number of subjects: 31

Group type: COMPARATOR
Intervention: 63.0 Gy in 30 fractions in air (control group)
Number of subjects: 31
Study: 30840831

Group type: EXPERIMENTAL
Intervention: Leucocyte-rich platelet-rich plasma (LR-PRP) injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Crossover group (previously failed CSI, treated with LR-PRP)
Number of subjects: 80
Study: 29763594

Group type: EXPERIMENTAL
Intervention: Patient-Controlled Paravertebral Block (PVB)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Intravenous Patient-Controlled Analgesia (PCA)
Number of subjects: 171
Study: 27506923

Group type: EXPERIMENTAL
Intervention: STAT model (Specific Timely Appointments for Triage)
Number of subjects: 0
Study: 24695352

Group type: EXPERIMENTAL
Intervention: Efavirenz-containing regimen
Number of subjects: 360
Study: 20131679

Group type: EXPERIMENTAL
Intervention: Sensodyne Pronamel (1450 ppm F as NaF/5% KNO3)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Crest Cavity Protection (1100 ppm F as NaF)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Crest Pro‐Health (0.454% SnF2 [1100 ppm F]/sodium hexametaphosphate)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Blend‐a‐Med Classic (1450 ppm F as NaF)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Colgate Sensitive Multi Protection (1000 ppm F as NaMFP/5.53% potassium citrate/2% zinc citrate)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo control (0 ppm F)
Number of subjects: 170
Study: 15026923

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic colectomy (HALC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 60
Study: 11288047

Group type: EXPERIMENTAL
Intervention: Nicotinic acid (NA) 7.4 mg.kg(‐1) body weight before exercise and 3.7 mg.kg(‐1) at 0 and 30 minutes of exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 6
Study: 9237961

Group type: COMPARATOR
Intervention: Olestra 0 g/d
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Olestra 8 g/d
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Olestra 20 g/d
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Olestra 32 g/d
Number of subjects: 90
Study: 8422080

Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 3612781

Group type: EXPERIMENTAL
Intervention: Physical-fitness evaluation (PF)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Physical-fitness evaluation and health-hazard appraisal (PF-HA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (HA)
Number of subjects: 200
Study: 30910568

Group type: COMPARATOR
Intervention: Non-specific instruction ('do some [exercise]')
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Instruction A: 'do [exercise] 25 times'
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Instruction B: 'do [exercise] 25 times as fast as you can'
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Instruction C: 'do [exercise] 25 times, as fast as you can, aiming for a personal best'
Number of subjects: 24
Study: 29948822

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg TNK‐tPA
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg TNK‐tPA
Number of subjects: 112

Group type: COMPARATOR
Intervention: NINDS trial (historical control)
Number of subjects: 112
Study: 26825408

Group type: EXPERIMENTAL
Intervention: Vaginal packing (P)
Number of subjects: 77

Group type: COMPARATOR
Intervention: No vaginal packing (NP)
Number of subjects: 77
Study: 24176022

Group type: EXPERIMENTAL
Intervention: Light Transmission Aggregometry (LTA) with 10 μmol ADP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Verify Now P2Y12 (VN)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vasodilatator-stimulated phosphoprotein (VASP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Correlation between LTA and VN
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Correlation between LTA and VASP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Correlation between VN and VASP
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pre-specified cut-off points for defining responders
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single test poor responder definition
Number of subjects: 100
Study: 22882714

Group type: EXPERIMENTAL
Intervention: Multiprofessional team training in a medical simulation centre
Number of subjects: 74
Study: 19263121

Group type: EXPERIMENTAL
Intervention: High-pressure pneumoperitoneum (15 mmHg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-pressure pneumoperitoneum (7 mmHg)
Number of subjects: 52
Study: 17228023

Group type: EXPERIMENTAL
Intervention: Adjuvant fluorouracil (FU) treatment
Number of subjects: 542

Group type: COMPARATOR
Intervention: Surgery-alone group (untreated cohort)
Number of subjects: 542
Study: 15510093

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Epidural steroid injections
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Self-care education
Number of subjects: 32
Study: 11417926

Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Two-channel EEG recording during ECT
Number of subjects: 1
Study: 9627039

Group type: EXPERIMENTAL
Intervention: High-performance membranes (HPMs)
Number of subjects: 10